This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (9)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

JAMA. 1998;280:1472.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The FDA has approved an emergency contraception kit (Preven, Gynetics Inc, Somerville, NJ) that is indicated for the prevention of pregnancy in women after known or suspected contraceptive failure or unprotected intercourse. The kit is available by prescription. It consists of a patient information book, a urine pregnancy test, and four emergency contraceptive pills (ECPs), each containing the combination levonorgestrel (0.25 mg) and ethinyl estradiol (0.05 mg).

The professional labeling, patient information, and other material regarding Preven are available at FDA's new drug approval package site on the Internet: http://www.fda.gov/cder/approval/index.htm.

The patient information book instructs the patient first on how to use the pregnancy test and specifies its limitations. If the test result is negative, the patient may use the ECPs. The initial two pills should be taken as soon as possible, but within 72 hours after unprotected intercourse. This is followed by the second dose of two pills . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Periconceptional Exposure to Efavirenz and Neural Tube Defects
De Santis et al.
Arch Intern Med 2002;162:355-355.
FULL TEXT